Caffeine analgesic adjuvancy with acetaminophen absent in Bristol-Myers data -- McNeil.
This article was originally published in The Tan Sheet
Executive Summary
CAFFEINE ANALGESIC ADJUVANCY NOT SHOWN BY BRISTOL-MYERS SUBMISSION, McNEIL maintains in a recent filing with FDA. The J&J unit is continuing to challenge Bristol-Myers Squibb's attempts to prove that caffeine is effective as an analgesic adjuvant with acetaminophen. Specifically, McNeil maintained that there are "serious carryover effects present in the Bristol-Myers Squibb data and their headache studies do not demonstrate caffeine's adjuvancy when combined with acetaminophen."